Angola vs India: New cases tested for RR-/MDR-TB
Angola
93.0%
in 2024
India
92.0%
in 2024
Angola rank
84th
India rank
87th
New cases tested for RR-/MDR-TB over time
- Angola
- India
How they compare
Angola currently reports 93.0% against 92.0% in India, a difference of 1.0%.
The two have swapped places 3 times across 10 shared years of data; in 2014 it was India ahead.
Angola ranks 84th and India ranks 87th of 192 countries.
India has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Angola | India | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17.3% | 44.9% | 27.6% | India |
| 2020s | 63.7% | 84.8% | 21.1% | India |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Angola or India?
- Angola, at 93.0% against 92.0% in India as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Angola and India?
- 1.0%, with Angola ahead.
- How many years of comparable data are there for Angola and India?
- 10 years are reported by both, from 2014 to 2024.
- How do Angola and India rank globally for new cases tested for rr-/mdr-tb?
- Angola ranks 84th and India ranks 87th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.